DSD-T269

Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T269

DSD-T269 · Gonadal dysgenesis · 2022 · Automated translation

Karyotype 46,XY

17α-hydroxylase/17,20-lyase deficiency (46,XX).

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Age

Not reported in the original text (young adult female)

Sex

Female, 46,XX

Karyotype

46,XY

Diagnosis

17α-hydroxylase/17,20-lyase deficiency (46,XX).

Follow-up

After treatment, blood pressure 125/75 mmHg and serum potassium 3.8 mmol/L; condition stable at follow-up in 2021.

General phenotype

Female phenotype, sexual infantilism, hypertension 160/110 mmHg.

Imaging

Ultrasound showed infantile uterus and ovaries; CT showed bilateral adrenal hyperplasia (more marked on the right).

Laboratory findings

K 3.2 mmol/L; E2 <18.35 mmol/L; T <0.087 mmol/L; DHEAS 0.764 μmol/L; FSH 15.64 mIU/ml; LH 18.71 mIU/ml; morning cortisol 92.96 nmol/L; ACTH 81.56 pg/mL; 17-OHP 0.1; aldosterone supine 486.7 pg/ml, upright 541.4 pg/ml; renin activity 0.18 ng/ml/h.

Management

Dexamethasone 0.75 g/day (as stated in the original text; presumably mg) initially; nifedipine 30 mg twice daily, spironolactone 40 mg twice daily.

Pathology

Not reported in the original text

Evidence level

See source

Perinatal history

See source

Growth and development

See source

External genital examination

See source

Genetics

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T269 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T269?version=v1.4.0